Category: Biologics
Biologics market research reports by GlobalData
-
Soft Tissue Biologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Soft Tissue Biologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Soft Tissue Biologics Pipeline Report including Stages of Development, Segments, Region and Count ... Read More
-
Celiac Disease: Competitive Landscape
Celiac Disease: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Celiac Disease therapeutics. In 2024, more than 3.7 million diagnosed prevalent cases of CD are anticipated in the 16 countries covered in GlobalData’s epidem ... Read More
-
M&A in the Contract Manufacturing Industry: Implications and Outlook – 2024 Edition
M&A in the Contract Manufacturing Industry: Implications and Outlook – 2024 Edition Summary This report is the fifth edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight ... Read More
-
Thematic Intelligence: The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update)
Thematic Intelligence: The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) Summary Although the pharmaceutical industry is often labeled as a recession-resistant, it is not immune to future challenges. Ongoing issues such as constraints on drug pricing and reimbursement (P&R ... Read More
-
Looking Ahead to 2024 - the Future of Pharma
Looking Ahead to 2024 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
Bone Biologics Corp (BBLG) - Product Pipeline Analysis, 2023 Update
Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company which develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers ... Read More
-
The State of the Biopharmaceutical Industry 2024 Edition
The State of the Biopharmaceutical Industry 2024 Edition Summary While the fight against COVID-19 is not in the distant past, it has been already overshadowed by a range of macroeconomic and geopolitical factors. At the same time, ongoing drug pricing and reimbursement constraints, regulatory pressu ... Read More
-
China Biologic Products Holdings Inc - Strategic SWOT Analysis Review
China Biologic Products Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo ... Read More
-
Anal Cancer (AC) - Competitive Landscape
Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More
-
Bone Grafts and Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Bone Grafts and Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Bone Grafts and Substitutes Pipeline Report including Stages of Development, Segments, Regi ... Read More
-
Metaverse in Healthcare - Thematic Intelligence
Metaverse in Healthcare - Thematic Intelligence Summary The metaverse will be worth $627 billion by 2030 The metaverse is a virtual world where users share experiences and interact in real-time within simulated scenarios. The metaverse brings together a range of technologies, from cloud computing to ... Read More
-
Soft Tissue Biologics Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033
Soft Tissue Biologics Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033 Summary Soft Tissue Biologics Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Re ... Read More
-
Mexico Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030
Mexico Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 Summary GlobalData’s “Mexico Orthobiologic Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on th ... Read More
-
State of the Biopharmaceutical Industry 2023
State of the Biopharmaceutical Industry 2023 Summary In this report, GlobalData examines the business environment and trends that are going to shape the biopharmaceutical industry in 2023. The report highlights the most impactful emerging technologies, industry trends, regulatory trends, and microec ... Read More
-
Diabetic Foot Ulcers Market Size, Share and Trends Analysis by Region, Treatment (Biologics, Wound Care Dressings, Therapy Devices, and Others), Ulcers Type (Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers), End-user (Homecare Settings, Hos
Diabetic Foot Ulcers Market Size, Share and Trends Analysis by Region, Treatment (Biologics, Wound Care Dressings, Therapy Devices, and Others), Ulcers Type (Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers), End-user (Homecare Settings, Hospitals and Specialty Clinics, Others) and Seg ... Read More
-
Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-202
Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027 Summary The Regenerative Medicine in Pharma ... Read More
-
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 Summary The Global Atopic Dermatitis market size was value ... Read More
-
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Contract Injectable Packaging Trends in the Bio/Pharma Industry Summary This expert trend report is a comprehensive look at the injectable packaging landscape in 2022, including analysis of packaging outsourcing relationships for drugs, packaging companies and facilities. It is a critical source for ... Read More
-
Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Comp ... Read More
Research Assistance
